Alterations induced by the antifungal compounds ketoconazole and terbinafine in Leishmania.
The antiproliferative effects and ultrastructural alterations induced in vitro by two antifungal compounds, the azole ketoconazole and the allylamine terbinafine on Leishmania amazonensis are reported. Promastigotes treatment with ketoconazole and terbinafine induced growth arrest and cell lysis in 72 hours. Combination of the two agents produced additive effects on promastigote axenic growth and synergistic effects on intracellular amastigote proliferation. The amastigotes, either axenically grown or infecting murine macrophages, were about 100-fold more sensitive to the drugs. These compounds induced the appearance of large multivesicular bodies, especially after ketoconazole treatment, increased amount of lipid inclusions as well as numerous, polymorphic volutin granules, particularly in terbinafine-treated cells. Multivesicular bodies were observed in close apposition with organelles such as mitochondria, which also showed alterations in the distribution and appearance of cristae, and the formation of paracrystalline arrays within the matrix. Some cells presented large portions of cytoplasm wrapped by endoplasmic reticulum and many parasites also presented myelin-like endoplasmic reticulum profiles. Such alterations together with the strong acid phosphatase activity observed in the multivesicular bodies and volutin granules may indicate the existence of an unusual autophagic process in cells treated with ergosterol biosynthesis inhibitors.
Vannier-Santos
M A
MA
Programa de Parasitologia e Biologia Celular, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Brasil.
Urbina
J A
JA
Martiny
A
A
Neves
A
A
de Souza
W
W
D000135:Acid Phosphatase / Q000032:analysis; D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology*; D000981:Antiprotozoal Agents / Q000494:pharmacology*; D004347:Drug Interactions; D004875:Ergosterol / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D006790:Host-Parasite Interactions / Q000187:drug effects; D006801:Humans; D007654:Ketoconazole / Q000494:pharmacology*; D007894:Leishmania mexicana / Q000187:drug effects* / Q000502:physiology; D016773:Leishmaniasis, Cutaneous / Q000469:parasitology*; D017737:Macrophages, Peritoneal / Q000469:parasitology; D051379:Mice; D008854:Microscopy, Electron; D009281:Naphthalenes / Q000494:pharmacology*; D015388:Organelles / Q000187:drug effects / Q000648:ultrastructure; D012098:Reproduction; D000077291:Terbinafine
D000935:Antifungal Agents; D000981:Antiprotozoal Agents; D009281:Naphthalenes; D000135:Acid Phosphatase; D000077291:Terbinafine; D007654:Ketoconazole; D004875:Ergosterol